{"id":12,"date":"2016-04-11T19:13:52","date_gmt":"2016-04-11T19:13:52","guid":{"rendered":"https:\/\/mdvaluecare.com\/?page_id=12"},"modified":"2024-03-19T13:32:52","modified_gmt":"2024-03-19T17:32:52","slug":"public-reporting","status":"publish","type":"page","link":"https:\/\/mdvaluecare.com\/public-reporting\/","title":{"rendered":"Public Reporting"},"content":{"rendered":"

ACO Name and Location<\/h3>\n

MD Valuecare, LLC
\n4900 Cox Road, Suite 200
\nGlen Allen, VA 23060<\/p>\n

ACO Primary Contacts<\/h3>\n

Ms. Lauren Steckler<\/a>
\nlsteckler@cvhn.com<\/a>\u00a0{{{{CHANGE TO ENVERA HEALTH ON PUBLIC LAUNCH DATE}}}}
\n<\/strong>804-955-1773<\/p>\n

Types of ACO Participants, or Combinations of Participants, that Formed the ACO<\/h2>\n

Network of individual practices of ACO professionals<\/p>\n

ACO Participants<\/h3>\n

Commonwealth Primary Care<\/a><\/p>\n

Dominion Medical Associates<\/a><\/p>\n

Lee Davis Medical Associates<\/a><\/p>\n

Virginia Diabetes and Endocrinology<\/a><\/p>\n

Virginia Family Physicians<\/a><\/p>\n

ACO Governing Body<\/h3>\n

 <\/p>\n

\"roger-capello\"<\/p>\n

Dr. Roger Cappello, Voting Member and Chair, Lee Davis Medical Associates<\/a><\/em><\/p>\n

 <\/p>\n

\"cathy-cawley\"<\/p>\n

Ms. Ann Honeycutt<\/a>, Voting Member and Vice Chair, Virginia Cardiovascular Specialists<\/a><\/em><\/p>\n

Ms. Cathy Cawley<\/a>, Voting Member, Commonwealth Primary Care<\/a><\/em><\/p>\n

 <\/p>\n

\"yevonne-childers\"<\/p>\n

Ms. Yevonne Childers<\/a>, Voting Member, Lee Davis Medical Associates<\/a><\/em><\/p>\n

 <\/p>\n

\"damian-covington\"<\/p>\n

Dr. Damian Covington, Voting Member, Dominion Medical Associates<\/a><\/em><\/p>\n

 <\/p>\n

\"paul-mctamaney\"<\/p>\n

Dr. Paul McTamaney, Voting Member, Medicare Beneficiary Representative<\/em><\/p>\n

 <\/p>\n

\"dave-taminger\"<\/p>\n

Dr. Dave Taminger, Voting Member, Virginia Family Physicians<\/a><\/em><\/p>\n

 <\/p>\n

\"steve-young\"<\/p>\n

Dr. Steve Young, Voting Member, Virginia Diabetes and Endocrinology<\/a><\/em><\/p>\n

 <\/p>\n

\"ken-zelenak\"<\/p>\n

Dr. Ken Zelenak, Voting Member, Commonwealth Primary Care<\/a><\/em><\/p>\n

 <\/p>\n

Key Clinical and Administrative Leadership<\/h3>\n

 <\/p>\n

\"michael-matthews\"<\/p>\n

ACO Executive: Mr. Michael Matthews<\/a><\/em><\/p>\n

 <\/p>\n

\"stephen-cavalieri\"<\/p>\n

Medical Director: Dr. Stephen Cavalieri<\/a><\/em><\/p>\n

 <\/p>\n

\"lauren-steckler\"<\/p>\n

Compliance Contact, Public Contact, Marketing Contact, CMS Liaison: Ms. Lauren Steckler<\/em><\/p>\n

ACO Committees and Committee Leadership<\/h3>\n

 <\/p>\n

\"ken-zelenak\"<\/p>\n

Quality Assurance and Improvement Committee: Dr. Ken Zelenak, Chair<\/em><\/p>\n

 <\/p>\n

\"tom-gallo\"<\/p>\n

Administration Committee: Mr. Tom Gallo<\/a>, Chair<\/em><\/p>\n

 <\/p>\n

\"tom-gallo\"<\/p>\n

Managing Committee: Mr. Tom Gallo<\/a>, Chair<\/em><\/p>\n

Amount of Shared Savings and Losses<\/h2>\n

Performance Year 1: $0<\/p>\n

Performance Year 2: Not yet determined<\/p>\n

Performance Year 3: Not yet determined<\/p>\n

How Shared Savings Are Distributed<\/h2>\n

Proportion invested in infrastructure: Not yet determined<\/p>\n

Invested in redesigned care processes\/resources: Not yet determined<\/p>\n

Proportion of distribution to ACO participants: Not yet determined<\/p>\n

2014 Performance Summary Statistics<\/h3>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Performance Measure<\/th>2012
\nACO Performance
\nRate (%)<\/th>		2012
\nMean Performance
\nRate for All ACOs (%)<\/th>		2013
\nACO Performance
\nRate (%)<\/th>		2013
\nMean Performance
\nRate for All ACOs (%)<\/th>		2014
\nACO Performance
\nRate (%)<\/th>		2014
\nMean Performance
\nRate for All ACOs (%)<\/th>\n<\/tr>\n<\/thead>\n
Getting Timely Care, Appointments, and Information (ACO-1)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>81.38<\/td>80.13<\/td>\n<\/tr>\n
How Well Your Doctors Communicate (ACO-2)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>91.78<\/td>92.39<\/td>\n<\/tr>\n
Patients\u2019 Rating of Doctor (ACO-3)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>91.32<\/td>91.58<\/td>\n<\/tr>\n
Access to Specialists (ACO-4)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>83.43<\/td>83.97<\/td>\n<\/tr>\n
Health Promotion and Education (ACO-5)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>58.64<\/td>58.29<\/td>\n<\/tr>\n
Shared Decision Making (ACO-6)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>75.35<\/td>74.60<\/td>\n<\/tr>\n
Health Status\/Functional Status (ACO-7)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>72.18<\/td>71.10<\/td>\n<\/tr>\n
Risk Standardized, All Condition Readmissions (ACO-8)*<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>14.52<\/td>15.15<\/td>\n<\/tr>\n
ASC Admissions: COPD or Asthma in Older Adults (ACO-9)*<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>0.66<\/td>1.08<\/td>\n<\/tr>\n
ASC Admission: Heart Failure (ACO-10)*<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>1.18<\/td>1.19<\/td>\n<\/tr>\n
Percent of Primary Care Providers who Qualified for EHR Incentive Payment (ACO-11)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>91.30<\/td>76.71<\/td>\n<\/tr>\n
Medication Reconciliation (ACO-12)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>34.93<\/td>82.61<\/td>\n<\/tr>\n
Falls: Screening for Fall Risk (ACO-13)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>58.89<\/td>45.60<\/td>\n<\/tr>\n
Influenza Immunization (ACO-14)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>62.27<\/td>57.51<\/td>\n<\/tr>\n
Pneumococcal Vaccination (ACO-15)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>65.31<\/td>55.03<\/td>\n<\/tr>\n
Adult Weight Screening and Follow-up (ACO-16)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>55.74<\/td>66.75<\/td>\n<\/tr>\n
Tobacco Use Assessment and Cessation Intervention (ACO-17)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>91.71<\/td>86.79<\/td>\n<\/tr>\n
Depression Screening (ACO-18)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>46.87<\/td>39.27<\/td>\n<\/tr>\n
Colorectal Cancer Screening (ACO-19)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>54.19<\/td>56.14<\/td>\n<\/tr>\n
Mammography Screening (ACO-20)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>60.33<\/td>61.41<\/td>\n<\/tr>\n
Proportion of Adults who had blood pressure screened in past 2 years (ACO-21)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>33.82<\/td>60.24<\/td>\n<\/tr>\n
Beneficiaries with diabetes who met of all the following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent) (ACO-22)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>75.12<\/td>N\/A<\/td>\n<\/tr>\n
Beneficiaries with diabetes who met of all the following criteria: Low Density Lipoprotein (LDL) (<100 mg\/dL) (ACO-23)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>N\/A<\/td>N\/A<\/td>\n<\/tr>\n
Beneficiaries with diabetes who met of all the following criteria: Blood Pressure (BP) <140\/90 (ACO-24)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>73.98<\/td>N\/A<\/td>\n<\/tr>\n
Beneficiaries with diabetes who met of all the following criteria: Tobacco Non-Use (ACO-25)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>91.65<\/td>N\/A<\/td>\n<\/tr>\n
Beneficiaries with diabetes who met of all the following criteria: Aspirin Use (ACO-26)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>84.92<\/td>N\/A<\/td>\n<\/tr>\n
Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) (ACO-27)*<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>12.11<\/td>20.35<\/td>\n<\/tr>\n
Percent of beneficiaries with hypertension whose BP <140\/90 (ACO-28)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>67.85<\/td>68.02<\/td>\n<\/tr>\n
Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg\/dl (ACO-29)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>N\/A<\/td>N\/A<\/td>\n<\/tr>\n
Percent of beneficiaries who use Aspirin or other antithrombotic (ACO-30)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>83.25<\/td>80.79<\/td>\n<\/tr>\n
Beta-Blocker Therapy for LVSD (ACO-31)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>74.77<\/td>82.71<\/td>\n<\/tr>\n
Percent of beneficiaries with CAD who met all of the following criteria: Drug Therapy for Lowering LDL-Cholesterol (ACO-32)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>N\/A<\/td>N\/A<\/td>\n<\/tr>\n
Percent of beneficiaries with CAD who met all of the following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and\/or (LVSD) (ACO-33)<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>not in operation<\/td>71.03<\/td>N\/A<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

*<\/strong>A lower performance rate indicates better performance.<\/p>\n","protected":false},"excerpt":{"rendered":"

ACO Name and Location MD Valuecare, LLC 4900 Cox Road, Suite 200 Glen Allen, VA 23060 ACO Primary Contacts Ms. Lauren Steckler lsteckler@cvhn.com\u00a0{{{{CHANGE TO ENVERA HEALTH ON PUBLIC LAUNCH DATE}}}} 804-955-1773 Types of ACO Participants, or Combinations of Participants, that Formed the ACO Network of individual practices of ACO professionals ACO Participants Commonwealth Primary Care Dominion Medical Associates Lee Davis […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-flex-content-no-sidebar.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/pages\/12"}],"collection":[{"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/comments?post=12"}],"version-history":[{"count":136,"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/pages\/12\/revisions"}],"predecessor-version":[{"id":901,"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/pages\/12\/revisions\/901"}],"wp:attachment":[{"href":"https:\/\/mdvaluecare.com\/wp-json\/wp\/v2\/media?parent=12"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}